参考文献/References:
[1] Wang YX,Wang YP,Zhang H,et al.Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor[J].Bioorg Med Chem Lett,2009,19(21):6004-6008.DOI:10.1016/j.bmcl.2009.09.059.
[2] Rahigude AB,Kaulaskar SV,Bhutada PS.Possible therapeutic potential of berberine in diabetic osteopathy[J].Med Hypotheses,2012,79(4):440-444.DOI:10.1016/j.mehy.2012.06.016.
[3] 张真稳. 小檗碱协同甘丙肽降低2型糖尿病鼠脂肪组织胰岛素抵抗的实验研究[D].扬州大学,2015.
[4] Kumar A,Ekavali,Chopra K,et al.Current knowledge and pharmacological profile of berberine: an update[J].Eur J Pharmacol,2015,761:288-297.DOI:10.1016/j.ejphar.2015.05.068.
[5] Hardie DG,Schaffer BE,Brunet A.AMPK: an energy-sensing pathway with multiple inputs and outputs[J].Trends Cell Biol,2016,26(3):190-201.DOI:10.1016/j.tcb.2015.10.013.
[6] van Marken Lichtenbelt WD,Vanhommerig JW,Smulders NM,et al.Cold-activated brown adipose tissue in healthy men[J].N Engl J Med,2009,360(15):1500-1508.DOI:10.1056/NEJMoa0808718.
[7] Virtanen KA,Lidell ME,Orava J,et al.Functional brown adipose tissue in healthy adults[J].N Engl J Med,2009,360(15):1518-1525.DOI:10.1056/NEJMoa0808949.
[8] Zhang Z,Zhang H,Li B,et al.Berberine activates thermogenesis in white and brown adipose tissue[J].Nat Commun,2014,5:5493.DOI:10.1038/ncomms6493.
[9] 王会玲,李燕,胡伟锋,等. 小檗碱影响AMPK/PGC-1信号途径改善糖尿病胰岛素抵抗和线粒体功能的研究[J].中华临床医师杂志(电子版),2014,8(5):896-901. DOI:10.3877/cma.j.issn.1674-0785.2014.05.019.
[10] Tian CM,Jiang X,Ouyang XX,et al.Berberine enhances antidiabetic effects and attenuates untoward effects of canagliflozin in streptozotocin-induced diabetic mice[J].Chin J Nat Med,2016,14(7):518-526.DOI:10.1016/S1875-5364(16)30061-9.
[11] Hardie DG.AMPK: positive and negative regulation, and its role in whole-body energy homeostasis[J].Curr Opin Cell Biol,2015,33:1-7.DOI:10.1016/j.ceb.2014.09.004.
[12] Cheng Z,Pang T,Gu M,et al.Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK[J].Biochim Biophys Acta,2006,1760(11):1682-1689. DOI:10.1016/j.bbagen.2006.09.007.
[13] Zhang M,Lv X,Li J,et al.Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis[J].Mol Cell Endocrinol,2012,363(1-2):122-130.DOI:10.1016/j.mce.2012.08.006.
[14] Li Y,Wang P,Zhuang Y,et al.Activation of AMPK by berberine promotes adiponectin multimerization in 3T3-L1 adipocytes[J].FEBS Lett,2011,585(12):1735-1740.DOI:10.1016/j.febslet.2011.04.051.
[15] Li Z,Geng YN,Jiang JD,et al.Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus[J].Evid Based Complement Alternat Med,2014,2014:289264.DOI:10.1155/2014/289264.
[16] 肖新华,张茜.小檗碱降糖调脂机制新进展[J].武警医学,2014,25(2):109-112. DOI:10.14010/j.cnki.wjyx.2014.02.010.
[17] Li Z,Jiang JD,Kong WJ.Berberine up-regulates hepatic low-density lipoprotein receptor through Ras-independent but AMP-activated protein kinase-dependent Raf-1 activation[J].Biol Pharm Bull,2014,37(11):1766-1775.DOI:10.1248/bpb.b14-00412.
[18] Hardie DG.Sensing of energy and nutrients by AMP-activated protein kinase[J].Am J Clin Nutr,2011,93(4):891S-896S.DOI:10.3945/ajcn.110.001925.
[19] Mihaylova MM,Shaw RJ.The AMPK signalling pathway coordinates cell growth, autophagy and metabolism[J].Nat Cell Biol,2011,13(9):1016-1023.DOI:10.1038/ncb2329.
[20] Guo S.Molecular basis of insulin resistance: the role of IRS and Foxo1 in the control of diabetes mellitus and its complications[J].Drug Discov Today Dis Mech,2013,10(1-2):e27-e33.DOI:10.1016/j.ddmec.2013.06.003.
[21] 汪忠煜,杨明炜,陈立,等.小檗碱与梓醇及其配伍对胰岛素抵抗3T3-L1脂肪细胞 Glut-4, IRS-1,IRS-1 Ser307磷酸化蛋白表达的影响[J].中国药师,2008,11(10):1142-1145. DOI:10.3969/j.issn.1008-049X.2008.10.004.
[22] Gu JJ,Gao FY,Zhao TY.A preliminary investigation of the mechanisms underlying the effect of berberine in preventing high-fat diet-induced insulin resistance in rats[J].J Physiol Pharmacol,2012,63(5):505-513.
[23] Zhang X,Zhao Y,Zhang M,et al.Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats[J].PLoS One,2012,7(8):e42529.DOI:10.1371/journal.pone.0042529.
[24] Chen F,Wen Q,Jiang J,et al.Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs[J].J Ethnopharmacol,2016,179:253-264.DOI:10.1016/j.jep.2015.12.031.
[25] Feng R,Shou JW,Zhao ZX,et al.Transforming berberine into its intestine-absorbable form by the gut microbiota[J].Sci Rep,2015,5:12155. DOI:10.1038/srep12155.
[26] 戎鑫仁,贺娅莎,王彦.盐酸小檗碱对糖尿病大鼠肠道菌群结构的影响[J]. 中西医结合心脑血管病杂志,2016,14(11):1221-1223.DOI:10.3969/j.issn.1672-1349.2016.11.012.
[27] 贺娅莎,王彦.小檗碱对2型糖尿病小鼠肠道菌群影响的相关研究[J]. 糖尿病新世界,2015,35(8):42-43.DOI:10.3969/j.JSSN.1672-1349.2016.11.012.
[28] 张静,吕毅. 肠道菌群失调诱发2型糖尿病的研究进展[J].中国微生态学杂志,2016,28(1):113-116.DOI:10.13381/j.cnki.cjm.201601029.
[29] Huang T, Yan X, Yan X, et al. Modulation of gut microbiota by berberine and decocted Coptis chinensis Franch. in a high-fat diet-induced metabolic syndrome rat model[J]. J Trad Chin Med Sci, 2017, 4(2): 149-157.DOI:10.101/j.jtcms.2017.05.005.
[30] Wang Y,Shou JW,Li XY,et al.Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism[J].Metabolism,2017,70:72-84.DOI:10.1016/j.metabol.2017.02.003.
[31] Xie W,Gu D,Li J,et al.Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice[J].PLoS One,2011,6(9):e24520.DOI:10.1371/journal.pone.0024520.
[32] Sun H,Wang N,Cang Z,et al. Modulation of microbiota-gut-brain axis by berberine resulting in improved metabolic status in high-fat diet-fed rats[J].Obes Facts,2016,9(6):365-378.DOI:10.1159/000449507.
相似文献/References:
[1]刘丹丹,王丽,史兴晔,等.脂肪酸受体GPR120影响胰岛素受体底物-1的表达[J].国际内分泌代谢杂志,2014,(06):371.[doi:10.3760/cma.j.issn.1673-4157.2014.06.003]
Liu Dandan*,Wang Li,Shi Xingye,et al.Regulation of fatty acid receptor GPR120 on the expression of insulin receptor substrate-1[J].International Journal of Endocrinology and Metabolism,2014,(05):371.[doi:10.3760/cma.j.issn.1673-4157.2014.06.003]
[2]李新萍,张萍,李晓玉.螺内酯对特发性醛固酮增多症患者胰岛β细胞功能的影响[J].国际内分泌代谢杂志,2014,(06):379.[doi:10.3760/cma.j.issn.1673-4157.2014.06.005]
Li Xinping,Zhang Ping,Li Xiaoyu..Effects of spironolactone on islet β cell function in patients with idiopathic hyperaldosteronism[J].International Journal of Endocrinology and Metabolism,2014,(05):379.[doi:10.3760/cma.j.issn.1673-4157.2014.06.005]
[3]胡雅琴,包玉倩.维生素D对非酒精性脂肪性肝病的保护作用[J].国际内分泌代谢杂志,2014,(06):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
Hu Yaqin,Bao Yuqian..Protective effect of vitamin D on non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2014,(05):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
[4]张琳,王晓琳,李小英.雄激素与糖脂代谢的关系[J].国际内分泌代谢杂志,2014,(05):351.[doi:10.3760/cma.j.issn.1673-4157.2014.05.018]
Zhang Lin,Wang Xiaolin,Li Xiaoying..The relationship between testosterone and glycolipid,metabolism[J].International Journal of Endocrinology and Metabolism,2014,(05):351.[doi:10.3760/cma.j.issn.1673-4157.2014.05.018]
[5]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[6]王锐 陆强 王术艺 朱东林 蒋韬 马宁 刘悦 李燕莉
贾晓娇 姚立新.血清25羟维生素D及vaspin水平与妊娠糖尿病关系的研究[J].国际内分泌代谢杂志,2015,(05):306.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.005]
Wang Rui,Lu Qiang,Wang Shuyi,et al.Relationship between serum 25-hydroxyvitamin D, vaspin and gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):306.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.005]
[7]黄祺 程海燕 卜瑞芳.1-磷酸鞘胺醇与胰岛素抵抗[J].国际内分泌代谢杂志,2015,(05):348.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.015]
Huang Qi,Cheng Haiyan,Bu Ruifang..Sphingosine-1-phosphate and insulin resistance[J].International Journal of Endocrinology and Metabolism,2015,(05):348.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.015]
[8]李少卿 王坚.2型糖尿病患者血25-羟维生素D3缺乏
对胰岛素抵抗及骨量的影响[J].国际内分泌代谢杂志,2015,(06):384.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.006]
Li Shaoqing*,Wang Jian..The influence of 25-hydroxyl vitamin D3 deficiency on insulin resistance and bone mass in patients with type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(05):384.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.06.006]
[9]李晶,董荣娜,于德民.有氧运动对胰岛素抵抗小鼠visfatin
表达的影响[J].国际内分泌代谢杂志,2016,36(01):10.[doi:10.3760/cma.j.issn.1673-4157.2016.01.003]
Li Jing,Dong Rongna,Yu Demin..Effects of aerobic exercise on the expression of visfatin in mice with insulin resistance[J].International Journal of Endocrinology and Metabolism,2016,36(05):10.[doi:10.3760/cma.j.issn.1673-4157.2016.01.003]
[10]张琳,费雯婕,宋光耀.网膜素与代谢综合征[J].国际内分泌代谢杂志,2016,36(01):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]
Zhang Lin*,Fei Wenjie,Song Guangyao..Omentin and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2016,36(05):42.[doi:10.3760/cma.j.issn.1673-4157.2016.01.010]